Drug
Inotuzumab Ozogamicin
Inotuzumab Ozogamicin: highest development phase Phase 3, developed by Pfizer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Inotuzumab ozogamicin NCT01232556 | Phase 3 | Lymphoma, Non-Hodgkin |
| Inotuzumab Ozogamicin NCT01363297 | Phase 2 | Acute Lymphocytic Leukemia |
Latest
No recent events.
Follow Inotuzumab Ozogamicin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.